![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Kremsner, Peter G.; Ahuad Guerrero, Rodolfo Andres; Arana-Arri, Eunate; Aroca Martinez, Gustavo Jose; Bonten, Marc; Chandler, Reynaldo; Corral, Gonzalo; Louis De Block, Eddie Jan; Ecker, Lucie; Justin Gabor, Julian; Garcia Lopez, Carlos Alberto; Gonzales, Lucy; Granados Gonzalez, Maria Angelica; Gorini, Nestor; Grobusch, Martin P.; Hrabar, Adrian D.; Junker, Helga; Kimura, Alan; Lanata, Claudio F.; Lehmann, Clara; Leroux-Roels, Isabel; Mann, Philipp; Fernando Martinez-Resendez, Michel; Ochoa, Theresa J.; Alberto Poy, Carlos; Reyes Fentanes, Maria Jose; Rivera Mejia, Luis Maria; Ruiz Herrera, Vida Veronica; Saez-Llorens, Xavier; Schoenborn-Kellenberger, Oliver; Schunk, Mirjam; Sierra Garcia, Alexandra; Vergara, Itziar; Verstraeten, Thomas; Vico, Marisa und Oostvogels, Lidia
(2022):
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
In: Lancet Infectious Diseases, Bd. 22, Nr. 3: S. 329-340
Kremsner, Peter G.; Mann, Philipp; Kroidl, Arne; Leroux-Roels, Isabel; Schindler, Christoph; Gabor, Julian J.; Schunk, Mirjam; Leroux-Roels, Geert; Bosch, Jacobus J.; Fendel, Rolf; Kreidenweiss, Andrea; Velavan, Thirumalaisamy P.; Fotin-Mleczek, Mariola; Mueller, Stefan O.; Quintini, Gianluca; Schoenborn-Kellenberger, Oliver; Vahrenhorst, Dominik; Verstraeten, Thomas; de Mesquita, Margarida Alves; Walz, Lisa; Wolz, Olaf-Oliver und Oostvogels, Lidia
(2021):
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 A phase 1 randomized clinical trial.
In: Wiener Klinische Wochenschrift, Bd. 133, Nr. 17-18: S. 931-941
Viegas, Edna O.; Kroidl, Arne; Munseri, Patricia J.; Missanga, Marco; Nilsson, Charlotte; Tembe, Nelson; Bauer, Asli; Joachim, Agricola; Joseph, Sarah; Mann, Philipp; Geldmacher, Christof; Fleck, Sue; Stohr, Wolfgang; Scarlatti, Gabriella; Aboud, Said; Bakari, Muhammad; Maboko, Leonard; Hoelscher, Michael; Wahren, Britta; Robb, Merlin L.; Weber, Jonathan; McCormack, Sheena; Biberfeld, Gunnel; Jani, Ilesh; Sandstrom, Eric und Lyamuya, Eligius
(2018):
Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
In: PLOS One 13(11), e0206838 [PDF, 1MB]
In: PLOS One 13(11), e0206838 [PDF, 1MB]
Ake, Julie A.; Schuetz, Alexandra; Pegu, Poonam; Wieczorek, Lindsay; Eller, Michael A.; Kibuuka, Hannah; Sawe, Fredrick; Maboko, Leonard; Polonis, Victoria; Karasavva, Nicos; Weiner, David; Sekiziyivu, Arthur; Kosgei, Josphat; Missanga, Marco; Kroidl, Arne; Mann, Philipp; Ratto-Kim, Silvia; Eller, Leigh Anne; Earl, Patricia; Moss, Bernard; Dorsey-Spitz, Julie; Milazzo, Mark; Ouedraogo, G. Laissa; Rizvi, Farrukh; Yan, Jian; Khan, Amir S.; Peel, Sheila; Sardesai, Niranjan Y.; Michael, Nelson L.; Ngauy, Viseth; Marovich, Mary und Robb, Merlin L.
(2017):
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.
In: Journal of infectious Diseases, Bd. 216, Nr. 9: S. 1080-1090
Bauer, Asli; Podola, Lilli; Mann, Philipp; Missanga, Marco; Haule, Antelmo; Sudi, Lwitiho; Nilsson, Charlotta; Kaluwa, Bahati; Lueer, Cornelia; Mwakatima, Maria; Munseri, Patricia J.; Maboko, Leonard; Robb, Merlin L.; Tovanabutra, Sodsai; Kijak, Gustavo; Marovich, Mary; McCormack, Sheena; Joseph, Sarah; Lyamuya, Eligius; Wahren, Britta; Sandstrom, Eric; Biberfeld, Gunnel; Hölscher, Michael; Bakari, Muhammad; Kroidl, Arne und Geldmacher, Christof
(2017):
Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.
In: Journal of Virology, Bd. 91, Nr. 18, e00730-17
Joachim, Agricola; Bauer, Asli; Joseph, Sarah; Geldmacher, Christof; Munseri, Patricia J.; Aboud, Said; Missanga, Marco; Mann, Philipp; Wahren, Britta; Ferrari, Guido; Polonis, Victoria R.; Robb, Merlin L.; Weber, Jonathan; Tatoud, Roger; Maboko, Leonard; Hoelscher, Michael; Lyamuya, Eligius F.; Biberfeld, Gunnel; Sandström, Eric; Kroidl, Arne; Bakari, Muhammad; Nilsson, Charlotta und McCormack, Sheena
(2016):
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.
In: PLOS ONE 11(5), e0155702 [PDF, 1MB]
In: PLOS ONE 11(5), e0155702 [PDF, 1MB]
Munseri, Patricia. J.; Kroidl, Arne; Nilsson, Charlotta; Joachim, Agricola; Geldmacher, Christof; Mann, Philipp; Moshiro, Candida; Aboud, Said; Lyamuya, Eligius; Maboko, Leonard; Missanga, Marco; Kaluwa, Bahati; Mfinanga, Sayoki; Podola, Lilly; Bauer, Asli; Godoy-Ramirez, Karina; Marovich, Mary; Moss, Bernard; Hoelscher, Michael; Gotch, Frances; Stoehr, Wolfgang; Stout, Richard; McCormack, Sheena; Wahren, Britta; Mhalu, Fred; Robb, Merlin L.; Biberfeld, Gunnel; Sandstrom, Eric und Bakari, Muhammad
(2015):
Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial.
In: PLOS ONE 10(4), e0119629 [PDF, 787kB]
In: PLOS ONE 10(4), e0119629 [PDF, 787kB]